Akero Therapeutics, Inc. Insider Transactions
Purchase
Sell
Akero Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Graham G. Walmsley
Director |
Buy | 50,000 @ $43.55 | $2.18 M | 1,200,000 | 03/27/2025 | 03/27/2025 | |
|
Graham G. Walmsley
Director |
Buy | 58,691 @ $43.01 | $2.52 M | 1,150,000 | 03/26/2025 | 03/27/2025 | |
|
Graham G. Walmsley
Director |
Buy | 91,309 @ $44.75 | $4.09 M | 1,091,309 | 03/25/2025 | 03/27/2025 | |
|
Yale Catriona
Chief Development Officer |
Sell | 1,799 @ $45.05 | $81,045 | 95,034 | 03/17/2025 | 03/18/2025 | |
|
Yale Catriona
Chief Development Officer |
Sell | 8,201 @ $44.70 | $366,560 | 96,833 | 03/17/2025 | 03/18/2025 | |
|
Cheng Andrew
CEO |
Sell | 1,738 @ $44.88 | $78,001 | 654,324 | 03/12/2025 | 03/14/2025 | |
| Sell | 676 @ $44.88 | $30,339 | 61,959 | 03/12/2025 | 03/14/2025 | ||
|
Rolph Timothy
Chief Scientific Officer |
Sell | 516 @ $44.88 | $23,158 | 169,721 | 03/12/2025 | 03/14/2025 | |
|
Young Jonathan
COO |
Sell | 607 @ $44.88 | $27,242 | 200,540 | 03/12/2025 | 03/14/2025 | |
|
Yale Catriona
Chief Development Officer |
Sell | 614 @ $44.88 | $27,556 | 95,034 | 03/12/2025 | 03/14/2025 | |
|
Cheng Andrew
CEO |
Sell | 1,216 @ $42.31 | $51,453 | 656,062 | 03/10/2025 | 03/12/2025 | |
|
Cheng Andrew
CEO |
Sell | 28,784 @ $41.75 | $1.20 M | 657,278 | 03/10/2025 | 03/12/2025 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 3,162 @ $44.90 | $141,974 | 170,237 | 03/05/2025 | 03/07/2025 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 9,338 @ $44.40 | $414,617 | 173,399 | 03/05/2025 | 03/07/2025 | |
|
Young Jonathan
COO |
Sell | 38,553 @ $45.07 | $1.74 M | 201,147 | 03/04/2025 | 03/05/2025 | |
|
Young Jonathan
COO |
Sell | 11,447 @ $44.17 | $505,591 | 239,700 | 03/04/2025 | 03/05/2025 | |
|
Lamy Patrick
Senior VP, Commercial Strategy |
Sell | 1,000 @ $48.09 | $48,090 | 33,492 | 03/03/2025 | 03/05/2025 | |
|
Yale Catriona
Chief Development Officer |
Sell | 900 @ $50.63 | $45,571 | 95,648 | 02/18/2025 | 02/21/2025 | |
|
Yale Catriona
Chief Development Officer |
Sell | 9,100 @ $49.79 | $453,089 | 96,548 | 02/18/2025 | 02/21/2025 | |
|
Cheng Andrew
CEO |
Sell | 200 @ $55.81 | $11,162 | 686,062 | 02/10/2025 | 02/11/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akero Therapeutics, Inc. FAQ's
The list of insiders at Akero Therapeutics, Inc. includes Yale Catriona, Young Jonathan, Cheng Andrew, Rolph Timothy, Lamy Patrick, White William Richard, Graham G. Walmsley.
Insiders have sold a total of 458,852 Akero Therapeutics, Inc. shares in the last 12 months for a total of 21.34 M sold.
The following insiders have sold Akero Therapeutics, Inc. shares in the last 12 months: Yale Catriona ($7.94 M), Young Jonathan ($3.49 M), Cheng Andrew ($5.60 M), Rolph Timothy ($3.77 M), Lamy Patrick ($419,981), White William Richard ($117,074),
Insiders have purchased a total of 400,000 Akero Therapeutics, Inc. shares in the last 12 months for a total of 18.39 M.
The following insiders have purchased Akero Therapeutics, Inc. shares in the last 12 months: Graham G. Walmsley ($18.39 M),